dimethylarginine

nitric oxide synthase 3 ; Homo sapiens







38 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 35170653 The relationship between reduced choroidal thickness due to high plasma asymmetrical dimethylarginine level and increased severity of diabetic retinopathy. 2022 Feb 14 1
2 33413061 Asymmetric Dimethylarginine: a Key Player in the Pathophysiology of Endothelial Dysfunction, Vascular Inflammation and Atherosclerosis in Rheumatoid Arthritis? 2021 1
3 33864889 Metabolome and lipidome derangements during a severe mast cell activation event in a patient with indolent systemic mastocytosis. 2021 Dec 1
4 34564325 Reduced L-Arginine and L-Arginine-ADMA-Ratio, and Increased SDMA after Norseman Xtreme Triathlon. 2021 Aug 31 2
5 32814314 Increased Serum Levels of Asymmetric Dimethylarginine and Symmetric Dimethylarginine and Decreased Levels of Arginine in Sudanese Patients with Essential Hypertension. 2020 1
6 29372262 Vascular endothelium dysfunction: a conservative target in metabolic disorders. 2018 May 1
7 30256050 Asymmetric dimethylarginine and angiogenesis: biological significance. 2018 Dec 1
8 26759218 Evaluation of Endothelial (dys)Function, Left Ventricular Structure and Function in Patients with Chronic Kidney Disease. 2016 1
9 26959555 Asymmetric Dimethylarginine Stimulates Akt1 Phosphorylation via Heat Shock Protein 70-Facilitated Carboxyl-Terminal Modulator Protein Degradation in Pulmonary Arterial Endothelial Cells. 2016 Aug 1
10 27091343 Asymmetric Dimethylarginine Limits the Efficacy of Simvastatin Activating Endothelial Nitric Oxide Synthase. 2016 Apr 18 2
11 27345001 Association between Asymmetric Dimethylarginine and Pentosidine in Dialysis Effluent of Peritoneal Dialysis Patients -A possible intraperitoneal crosstalk between asymmetric dimethylarginine and advanced glycation end products in peritoneal dialysis patients. 2016 Jun 20 1
12 27417628 Asymmetric Dimethylarginine Is a Well Established Mediating Risk Factor for Cardiovascular Morbidity and Mortality-Should Patients with Elevated Levels Be Supplemented with Citrulline? 2016 Jul 8 2
13 25848469 Endothelial dysfunction in cirrhosis: Role of inflammation and oxidative stress. 2015 Mar 27 1
14 26091577 Asymmetric dimethyl arginine induces pulmonary vascular dysfunction via activation of signal transducer and activator of transcription 3 and stabilization of hypoxia-inducible factor 1-alpha. 2015 Oct 2
15 26385052 Pharmacogenetic influence of eNOS gene variant on endothelial and glucose metabolism responses to L-arginine supplementation: Post hoc analysis of the L-arginine trial. 2015 Nov 1
16 26527496 Effect of protein arginine methyltransferase-1 inhibition on hypoxia-induced vasoconstriction. 2015 Dec 1
17 23255608 Asymmetric dimethylarginine induces endothelial nitric-oxide synthase mitochondrial redistribution through the nitration-mediated activation of Akt1. 2013 Mar 1 2
18 20926145 The impact of rapid atrial pacing on ADMA and endothelial NOS. 2012 Jan 26 1
19 22336756 Endothelial nitric oxide synthase enhancer for protection of endothelial function from asymmetric dimethylarginine-induced injury in human internal thoracic artery. 2012 Sep 3
20 22558392 A functional variant of the dimethylarginine dimethylaminohydrolase-2 gene is associated with insulin sensitivity. 2012 1
21 26105457 PP135. Maternal serum levels of endothelial nitric oxide synthase and ADMA, an endogenous ENOS inhibitor in pregnancies complicated by severe preeclampsia. 2012 Jul 2
22 21644402 Plasma asymmetric dimethylarginine levels in healthy people. 2011 Jan-Mar 1
23 20598027 Glu298Asp polymorphism of the endothelial nitric oxide synthase gene and plasma concentrations of asymmetric dimethylarginine in Turkish pre-eclamptic women without fetal growth retardation. 2010 Jun 1
24 19297385 Association of plasma asymmetrical dimethylarginine (ADMA) with elevated vascular superoxide production and endothelial nitric oxide synthase uncoupling: implications for endothelial function in human atherosclerosis. 2009 May 2
25 19331593 Dimethylarginine dimethylaminohydrolase regulation: a novel therapeutic target in cardiovascular disease. 2009 Mar 1
26 19332631 Correlation of biomarkers of endothelium dysfunction and matrix remodeling in patients with systemic sclerosis. 2009 May 1
27 19486510 A study of endothelial function and circulating asymmetric dimethylarginine levels in people with Type 1 diabetes without macrovascular disease or microalbuminuria. 2009 Jun 1 1
28 19644064 Association of plasma ADMA levels with MRI markers of vascular brain injury: Framingham offspring study. 2009 Sep 1
29 19803415 The emerging role of symmetric dimethylarginine in vascular disease. 2009 1
30 19809994 Asymmetric dimethylarginine, vascular calcifications and parathyroid hormone serum levels in hemodialysis patients. 2009 Sep-Oct 1
31 18792879 Asymmetric dimethylarginine (ADMA) and other endogenous nitric oxide synthase (NOS) inhibitors as an important cause of vascular insulin resistance. 2008 Sep 1
32 17406107 Serum asymmetric dimethylarginine negatively correlates with intima-media thickness in early-onset atherosclerosis. 2007 1
33 17505150 Asymmetric dimethylarginine levels in thyroid diseases. 2007 Mar 1
34 17977009 Nebivolol reduces asymmetric dimethylarginine in endothelial cells by increasing dimethylarginine dimethylaminohydrolase 2 (DDAH2) expression and activity. 2007 Dec 1
35 18167189 Dysfunction of endothelial NO system originated from homocysteine-induced aberrant methylation pattern in promoter region of DDAH2 gene. 2007 Dec 5 1
36 16009421 Reduced L-arginine level and decreased placental eNOS activity in preeclampsia. 2006 Apr-May 2
37 16384887 Fast and efficient determination of arginine, symmetric dimethylarginine, and asymmetric dimethylarginine in biological fluids by hydrophilic-interaction liquid chromatography-electrospray tandem mass spectrometry. 2006 Mar 1
38 14551376 Impact of vitamin E on plasma asymmetric dimethylarginine (ADMA) in chronic kidney disease (CKD): a pilot study. 2003 Nov 1